Germany· DE-A57-5a6c083e78379ecc
Convulex
A valproic acid product containing valproic acid, registered in Germany by G.L. Pharma Gmbh. The same ATC class is registered in 16 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Valproic acid is registered in 16 of 19 countries.
Countries holding a registration under ATC N03AG01 (valproic acid), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 9 of them publish a price we can compare per daily dose
Valproic acid · ATC N03AG01
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of valproic acid costs, country by country.
Normalised to the WHO defined daily dose (1.5 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Valproic acid · price per daily dose (1.5 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.61
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Valproic Acid
- Manufacturer
- G.L. Pharma Gmbh
- Country
- Germany (DE)
- ATC code
- N03AG01
- ATC class
- Valproic acid
- Defined daily dose
- 1.5 g, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
391 interactions on record for valproic acid.
Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Valproic acid · interactions on record
391 records
- 9 severe
- 132 moderate
- 23 minor
- 189 info
Most severe, free to view
- Glycerol phenylbutyrateA16AX09severe
- BexaroteneL01XF03severe
- VorinostatL01XH01severe
- BexarotenL01XX25severe
38 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Valproic acid in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesValproicAphena Pharma Solutions - Tennessee, LLC
- United KingdomBelvo 250mg gastro-resistant tabletsConsilient Health Ltd
- FranceDEPAKINE 200 mg/ml, solution buvableSANOFI WINTHROP INDUSTRIE
- NetherlandsDepakine Enteric 300 mg, maagsapresistente tablettenEuro Registratie Collectief B.V.
- CanadaAPO-DIVALPROEXAPOTEX INC
- SpainACIDO VALPROICO ALTAN 400 mg POLVO PARA SOLUCION INYECTABLE EFGAltan Pharmaceuticals S.A.
- SwitzerlandConvulex
- ItalyDEPAKINSANOFI S.R.L.
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Austria · Convulex
- Bulgaria · Convulex, Конвулекс
- Czechia · Convulex
- Estonia · Convulex
- United Kingdom (Northern Ireland) · Convulex
- Hungary · Convulex
- Lithuania · Convulex
- Latvia · Convulex
- Poland · Convulex, Convulex 150
- Portugal · Ácido Valpróico Generis
- Romania · Convulex
- Slovakia · Convulex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4072db3f-2df0-4db8-8777-540fe7034f8d GET /v1/drugs/4072db3f-2df0-4db8-8777-540fe7034f8d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Valproic Acid",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about valproic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.